Noninvasive real-time monitoring by alamarBlue® during in vitro culture of three-dimensional tissue-engineered bone constructs

Tissue Engineering - Part C: Methods

Volumn 19, Issue 9, 2013, Pages 720-727

  Zhou, Xiaohua ^a   Holsbeeks, Inge ^a,b   Impens, Saartje ^a,b   Sonnaert, Maarten ^b   Bloemen, Veerle ^a,b   Luyten, Frank ^b   Schrooten, Jan ^b  

^a Associatie KULeuven   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCONVERSION; BIOREACTORS; BONE; CELL PROLIFERATION; METABOLISM; SCAFFOLDS (BIOLOGY); THREE DIMENSIONAL;

ANALYSIS TECHNIQUES; BONE TISSUE ENGINEERING; LINEAR CORRELATION; METABOLIC ACTIVITY; NONINVASIVE ANALYSIS; PERFUSION BIOREACTOR; REAL TIME MONITORING; TISSUE-ENGINEERED BONES;

PROCESS CONTROL;

GREEN FLUORESCENT PROTEIN; OXAZINE DERIVATIVE; RESAZURIN; TISSUE SCAFFOLD; TITANIUM; XANTHENE DERIVATIVE;

ARTICLE; BIOREACTOR; BONE; COMPUTER SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; METHODOLOGY; PERFUSION; PHYSIOLOGY; TIME; TISSUE CULTURE TECHNIQUE; TISSUE ENGINEERING;

BIOREACTORS; BONE AND BONES; COMPUTER SYSTEMS; GREEN FLUORESCENT PROTEINS; HUMANS; OXAZINES; PERFUSION; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TITANIUM; XANTHENES;

EID: 84880579526     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2012.0601     Document Type: Article

References (53)

1. Schneider, C.K., Salmikangas, P., Jilma, B., Flamion, B., Todorova, L.R., Paphitou, A., et al. Challenges with advanced therapy medicinal products and how to meet them. Nature Reviews Drug Discovery 9, 195, 2010.
2. European Medicines Agency. Guideline on Human Cell-Based Medicinal Products. EMEA/CHMP/410869/2006, 2007.
3. European Medicines Agency. EMEA/724428/2009. Assement report for Chondro Celect. Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins. Procedure No. EMEA/H/C/000878.2009.
4. Salter, E., Goh, B., Hung, B., Hutton, D., Ghone, N., and Grayson, W.L. Bone tissue engineering bioreactors: a role in the clinic? Tissue Eng Part B Rev 18, 62, 2012.
5. Rauh, J., Milan, F., Gunther, K.P., and Stiehler, M. Bioreactor systems for bone tissue engineering. Tissue Eng Part B Rev 17, 263, 2011.
6. Chrysanthopoulos, P.K., Goudar, C.T., and Klapa, M.I. Metabolomics for high-resolution monitoring of the cellular physiological state in cell culture engineering. Metab Eng 12, 212, 2010.
7. Janssen, F.W., Oostra, J., Oorschot, A., and van Blitterswijk, C.A. A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials 27, 315, 2006.
8. van Blitterswijk, A., Thomsen, P., Lindahl, A., Hubbell, J., Williams, D.F., Cancedda, R., et al. Tissue Engineering, 1 ed. Oxford: Elsevier, 2008.
9. Das, R.H., van Osch, G.J., Kreukniet, M., Oostra, J., Weinans, H., and Jahr, H. Effects of individual control of pH and hypoxia in chondrocyte culture. J Orthop Res 28, 537, 2010.
10. Santoro, R., Krause, C., Martin, I., and Wendt, D. On-line monitoring of oxygen as a non-destructive method to quantify cells in engineered 3D tissue constructs. J Tissue Eng Regen Med 6, 696, 2012.
11. Tsao, Y.S., Cardoso, A.G., Condon, R.G.G., Voloch, M., Lio, P., Lagos, J.C., et al. Monitoring Chinese hamster ovary cell culture by the analysis of glucose and lactate metabolism. J Biotechnol 118, 316, 2005.
12. Dittmar, R., Potier, E., van Zandvoort, M., and Ito, K. Assessment of cell viability in three-dimensional scaffolds using cellular auto-fluorescence. Tissue Eng Part C Methods 18, 198, 2012.
13. Gantenbein-Ritter, B., Potier, E., Zeiter, S., van der Werf, M., Sprecher, C.M., and Ito, K. Accuracy of three techniques to determine cell viability in 3D tissues or scaffolds. Tissue Eng Part C Methods 14, 353, 2008.
14. O'Brien, J., Wilson, I., Orton, T., and Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267, 5421, 2000.
15. Lee, J.K., Kim, D.B., Kim, J.I., and Kim, P.Y. In vitro cytotoxicity tests on cultured human skin fibroblasts to predict skin irritation potential of surfactants. Toxicol In Vitro 14, 345, 2000.
16. Finch, D.S., Oreskovic, T., Ramadurai, K., Herrmann, C.F., George, S.M., and Mahajan, R.L. Biocompatibility of atomic layer-deposited alumina thin films. J Biomed Mater Res Part A 87A, 100, 2008.
17. Al-Nasiry, S., Geusens, N., Hanssens, M., Luyten, C., and Pijnenborg, R. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22, 1304, 2007.
18. Voytik-Harbin, S.L., Brightman, A.O., Waisner, B., Lamar, C.H., and Badylak, S.F. Application and evaluation of the alamar Blue assay for cell growth and survival of fibroblasts. In Vitro Cell Dev Anim 34, 239, 1998.
19. Ahmed, S.A., Gogal, R.M., Jr., and Walsh, J.E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 170, 211, 1994.
20. Zhi-Jun, Y., Sriranganathan, N., Vaught, T., Arastu, S.K., and Ahmed, S.A. A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Methods 210, 25, 1997.
21. Page, B., Page, M., and Noel, C. A new fluorometric assay for cytotoxicity measurements in-vitro. Int J Oncol 3, 473, 1993.
22. Back, S.A., Khan, R., Gan, X.D., Rosenberg, P.A., and Volpe, J.J. A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death. J Neurosci Meth 91, 47, 1999.
23. Fields, R.D., and Lancaster, M.V. Dual-attribute continuous monitoring of cell-proliferation cytotoxicity. Am Biotechnol Lab 11, 48, 1993.
24. Czekanska, E.M. Assessment of cell proliferation with resazurin-based fluorescent dye. Methods Mol Biol 740, 27, 2011.
25. Abu-Amero, K.K., and Bosley, T.M. Detection of mitochondrial respiratory dysfunction in circulating lymphocytes using resazurin. Arch Pathol Lab Med 129, 1295, 2005.
26. Cui, Z.F., Xu, X., Trainor, N., Triffitt, J.T., Urban, J.P., and Tirlapur, U.K. Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing. Toxicol In Vitro 21, 1318, 2007.
27. van Gaalen, S.M., de Bruijn, J.D., Wilson, C.E., van Blitterswijk, C.A., Verbout, A.J., Alblas, J., et al. Relating cell proliferation to in vivo bone formation in porous Ca/P scaffolds. J Biomed Mater Res Part A 92A, 303, 2010.
28. Mueller, D., Tasher, G., Damm, G., Nüssler, A.K., Heinzle, E., and Noor, F. Real-time in situ viability assessment in a 3D bioreactor with liver cells using resazurin assay. Cytotechnology 65, 297, 2013.
29. Wilson, C.E., Dhert, W.J., Van Blitterswijk, C.A., Verbout, A.J., and De Bruijn, J.D. Evaluating 3D bone tissue engineered constructs with different seeding densities using the alamar Blue assay and the effect on in vivo bone formation. J Mater Sci Mater Med 13, 1265, 2002.
30. Chen, Y., Sonnaert, M., Roberts, S.J., Luyten, F.P., and Schrooten, J.I. Validation of a Pico Green-based DNA quantification integrated in an RNA extraction method for twodimensional and three-dimensional cell cultures. Tissue Eng Part C Methods 18, 444, 2012.
31. Impens, S., Chen, Y., Mullens, S., Luyten, F., and Schrooten, J. Controlled cell-seeding methodologies: a first step toward clinically relevant bone tissue engineering strategies. Tissue Eng Part C Methods 16, 1575, 2010.
32. De Bari, C., Dell'Accio, F., Vanlauwe, J., Eyckmans, J., Khan, I.M., Archer, C.W., et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 54, 1209, 2006.
33. Roberts, S.J., Geris, L., Kerckhofs, G., Desmet, E., Schrooten, J., and Luyten, F.P. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials 32, 4393, 2011.
34. Van Bael, S., Kerckhofs, G., Moesen, M., Pyka, G., Schrooten, J., and Kruth, J.P. Micro-CT-based improvement of geometrical and mechanical controllability of selective laser melted Ti6Al4V porous structures. Mater Sci Eng 528, 7423, 2011.
35. Palmquist, A., Snis, A., Emanuelsson, L., Browne, M., and Thomsen, P. Long-term biocompatibility and osseointegration of electron beam melted, free-form-fabricated solid and porous titanium alloy: experimental studies in sheep. J Biomater Appl 2011 [Epub ahead of print]. DOI: 10.1177/0885328211431857
36. Truscello, S., Kerckhofs, G., Van Bael, S., Pyka, G., Schrooten, J., and Van Oosterwyck, H. Prediction of permeability of regular scaffolds for skeletal tissue engineering: a combined computational and experimental study. Acta Biomater 8, 1648, 2012.
37. Pyka, G., Burakowski, A., Kerckhofs, G., Moesen, M., Van Bael, S., Schrooten, J., et al. Surface modification of Ti6Al4V open porous structures produced by additive manufacturing. Adv Eng Mater 14, 363, 2012.
38. Kerckhofs, G., Schrooten, J., Van Cleynenbreugel, T., Lomov, S.V., and Wevers, M. Validation of x-ray microfocus computed tomography as an imaging tool for porous structures. Rev Sci Instrum 79, 013711, 2008.
39. Kim, K., Dean, D., Mikos, A.G., and Fisher, J.P. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on crosslinked poly(propylene fumarate) disks. Biomacromolecules 10, 1810, 2009.
40. Chen, Y., Bloemen, V., Impens, S., Moesen, M., Luyten, F.P., and Schrooten, J. Characterization and optimization of cell seeding in scaffolds by factorial design: quality by design approach for skeletal tissue engineering. Tissue Eng Part C Methods 17, 1211, 2011.
41. Gazzano Santoro, H., Ralph, P., Ryskamp, T.C., Chen, A.B., and Mukku, V.R. A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody. J Immunol Methods 202, 163, 1997.
42. Gloeckner, H., Jonuleit, T., and Lemke, H.D. Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue (TM). J Immunol Methods 252, 131, 2001.
43. Byth, H.A., McHunu, B.I., Dubery, I.A., and Bornman, L. Assessment of a simple, non-toxic Alamar blue cell survival assay to monitor tomato cell viability. Phytochem Anal 12, 340, 2001.
44. Nociari, M.M., Shalev, A., Benias, P., and Russo, C. A novel one-step, highly sensitive fluorometric assay to evaluate cellmediated cytotoxicity. J Immunol Methods 213, 157, 1998.
45. Erikstein, B.S., Hagland, H.R., Nikolaisen, J., Kulawiec, M., Singh, K.K., Gjertsen, B.T., et al. Cellular stress induced by resazurin leads to autophagy and cell death via production of reactive oxygen species and mitochondrial impairment. J Cell Biochem 111, 574, 2010.
46. Nakayama, G.R., Caton, M.C., Nova, M.P., and Parandoosh, Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 204, 205, 1997.
47. Freshney, R.I. Basic principles of cell culture. In: Vunjak-Novakovic, G., Freshney, R.I., eds. Culture of Cells for Tissue Engineering. Hoboken, NJ: John Wiley & Sons, Inc., 2006, pp. 3-22.
48. Zhou, Y.F., Sae-Lim, V., Chou, A.M., Hutmacher, D.W., and Lim, T.M. Does seeding density affect in vitro mineral nodules formation in novel composite scaffolds? J Biomed Mater Res Part A 78A, 183, 2006.
49. Strehl, R., Schumacher, K., de Vries, U., and Minuth, W.W. Proliferating cells versus differentiated cells in tissue engineering. Tissue Eng 8, 37, 2002.
50. Truscello, S., Schrooten, J., and Van Oosterwyck H. A computational tool for the upscaling of regular scaffolds during in vitro perfusion culture. Tissue Eng Part C Methods 17, 619, 2011.
51. Grayson, W.L., Zhao, F., Izadpanah, R., Bunnell, B., and Ma, T. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 207, 331, 2006.
52. Pattappa, G., Heywood, H.K., De Bruijn, J.D., and Lee, D.A. The metabolism of human mesenchymal stem cells during proliferation and differentiation. J Cell Physiol 226, 2562, 2011.
53. Zhu, Z.G., Garcia-Gancedo, L., Flewitt, A.J., Xie, H.Q., Moussy, F., and Milne, W.I. A Critical review of glucose biosensors based on carbon nanomaterials: carbon nanotubes and graphene. Sensors 12, 5996, 2012.